The 1 analysts offering 12-month price forecasts for Interpace Biosciences Inc have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +18.11% increase from the last price of 7.62.
The current consensus among 1 polled investment analysts is to Buy stock in Interpace Biosciences Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.43
Reporting Date May 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.